Emtricitabine Completed Phase 4 Trials for Human Immunodeficiency Virus Type 1 (HIV-1) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02547844Evolution of Plasma Lipid Profile in Patients With HIV1 Who Change Atripla to Eviplera Compared to Continue With Atripla
NCT00324649Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to Truvada
NCT00772902ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial
NCT01274780Metabolic Effects of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine in naïve HIV-1 Infected Patients